A one-size-fits-all approach to prediabetes treatment may miss the opportunity to implement an early, more intensive, ...

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

Eli Lilly is the leader in the U.S. weight loss drug market, with a 60% share. Viking aims to enter this market -- and so far ...

Weight loss drugs have been linked to an increased risk of premature births among women who took them inadvertently just before or during early ...

Metformin use in people with diabetes was linked to a significantly lower risk of developing intermediate age-related macular degeneration.

Nearly 17 percent of Fiji’s population is living with diabetes, highlighting the growing burden of non-communicable diseases ...

Learn how an unlikely discovery in a venomous lizard led to one of today’s most influential drugs and why future ...

Some supplements that can lower blood sugar may lower it too much if you take them with medication. Other supplements may ...

A one-size-fits-all approach to prediabetes treatment may miss the opportunity to implement an early, more intensive, ...

In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...

A peer-reviewed analysis of U.S. adverse event data has found that patients taking Wegovy face nearly five times the risk of ...

Three new studies reveal surprising insights on GLP-1 weight loss drugs, opioid treatment in pregnancy, and the real science ...